Active Network offered 8.2 million shares in its flotation, and selling stockholders sold 2.8 million.
Month: May 2011
Softbank teams with Invest AD
The latest $100m fund will focus on Turkey after the two firms previously set up a $100m fund focused on Africa last year.
GE snaps up FMC-Tech
GE invested $55m in 12 companies in November from its $200m Ecomagination competition, including FMC-Tech.
Harvest Power gathers SAM tithe
SAM Private Equity provided the latest investment in Harvest Power and joins a consortium including New York-listed garbage disposal company Waste Management.
Reed rustles into GigaOm
Kevin Brown, partner at REV is joining GigaOm’s board after leading the $6m round.
QD Vision spies DTE Energy
Alongside DTE Energy Ventures in the consortium backing QD Vision’s $22m round were In-Q-Tel, which invests on behalf of the US intelligence services, and venture capital firms.
SK Telecom calls Billing Revolution
SK Telecom Ventures and venture capital firm DCM, as a new investor, co-led the series B round for Billing Revolution.
Tradeshift invoices for $7m
Tradeshift, a UK-based invoicing network for businesses, has raised $7m from venture capital firm Notion Capital, having previously had been seeded by online auction company eBay’s PayPal payments platform.
Pfizer lifts gloom with Neuronetics
Elaine Jones, executive director of Pfizer Venture Investments, will be an observer to Neuronetics’ board and said: “Pfizer has had a longstanding interest in treating depression.”
Ipsen breaks wishbone with Radius
At the initial closing of the financing, Radius received gross proceeds of $22m in equity and $6.25m in debt, and $1.4m of preferred stock was issued to Ipsen in lieu of a cash milestone payment.
BioCritica reaches healthy start
As part of a licensing agreement, BioCritica will acquire the US development and commercialization rights to Lilly’s Xigris treatment for severe sepsis and the rights to potentially acquire several critical care compounds currently in pre-clinical development at Lilly.
TetraLogic Pharma gains $6m
In September, Pfizer through its corporate venturing unit invested $5m in TetraLogic.
Yandex prices for IPO success
Yandex sold more than 52 million ordinary shares at $25 each compared to a planned $22 to $24 range, for an initial market cap of about $8bn before a 55% first day pop in its share price.
Wolfe at Citi’s door
US-based bank Citigroup has hired Trip Wolfe (pictured) to lead its venture capital coverage for North America.